163 related articles for article (PubMed ID: 29464661)
1. An unusual cause of cavitating leukoencephalopathy: ethylmalonic encephalopathy.
Cavusoglu D; Hismi BO; Dundar NO; Oztekin O; Koc A; Canda E; Arican P; Gencpinar P
Acta Neurol Belg; 2018 Jun; 118(2):309-312. PubMed ID: 29464661
[No Abstract] [Full Text] [Related]
2. Ethylmalonic Aciduria in an Infant with Neurological and Skin Presentation.
Peake RWA; Rodan LH
Clin Chem; 2017 Nov; 63(11):1771-1773. PubMed ID: 29089323
[No Abstract] [Full Text] [Related]
3. An infant with ethylmalonic encephalopathy masquerading as a hematologic disorder.
Pavlou E; Augoustides-Savvopoulou P; Gregersen N; Haas D; Gkampeta A; Athanassiadou-Piperopoulou F
J Child Neurol; 2013 May; 28(5):668-71. PubMed ID: 22805253
[TBL] [Abstract][Full Text] [Related]
4. Diffusion restriction in ethylmalonic encephalopathy - An imaging evidence of the pathophysiology of the disease.
Bhat MD; Prasad C; Tiwari S; Chandra SR; Christopher R
Brain Dev; 2016 Sep; 38(8):768-71. PubMed ID: 26992475
[TBL] [Abstract][Full Text] [Related]
5. Liver transplant in ethylmalonic encephalopathy: a new treatment for an otherwise fatal disease.
Dionisi-Vici C; Diodato D; Torre G; Picca S; Pariante R; Giuseppe Picardo S; Di Meo I; Rizzo C; Tiranti V; Zeviani M; De Ville De Goyet J
Brain; 2016 Apr; 139(Pt 4):1045-51. PubMed ID: 26917598
[TBL] [Abstract][Full Text] [Related]
6. An atypically mild case of ethylmalonic encephalopathy with pathogenic ETHE1 variant.
Kashima DT; Sloan-Heggen CM; Gottlieb-Smith RJ; Barone Pritchard A
Am J Med Genet A; 2023 Jun; 191(6):1614-1618. PubMed ID: 36891747
[TBL] [Abstract][Full Text] [Related]
7. Teaching NeuroImages: Imaging in metabolic leukoencephalopathy, L-2-hydroxyglutaric aciduria.
Sivadasan S; S V; Sundaram S
Neurology; 2018 Oct; 91(16):e1549-e1550. PubMed ID: 30323080
[No Abstract] [Full Text] [Related]
8. The basis of inborn errors of metabolism for neuroradiologists.
Vairo F; Vedolin L
Top Magn Reson Imaging; 2011 Oct; 22(5):209-14. PubMed ID: 24562090
[TBL] [Abstract][Full Text] [Related]
9. Turkish case of ethylmalonic encephalopathy misdiagnosed as short chain acyl-CoA dehydrogenase deficiency.
Bulut FD; Kör D; Şeker-Yılmaz B; Gül-Mert G; Kılavuz S; Önenli-Mungan N
Metab Brain Dis; 2018 Jun; 33(3):977-979. PubMed ID: 29159724
[TBL] [Abstract][Full Text] [Related]
10. Mystery Case: An infant with developmental delay, epileptic spasms, and acrocyanosis.
Madaan P; Saini L; Vyas S; Attri SV; Sahu JK
Neurology; 2020 May; 94(21):939-942. PubMed ID: 32366539
[No Abstract] [Full Text] [Related]
11. Acute Strokelike Presentation and Long-term Evolution of Diffusion Restriction Pattern in Ethylmalonic Encephalopathy.
Lim J; Shayota BJ; Lay E; Elsea SH; Bekheirnia MR; Tessier MEM; Kralik SF; Rice GM; Soler-Alfonso C; Scaglia F
J Child Neurol; 2021 Sep; 36(10):841-852. PubMed ID: 33900143
[TBL] [Abstract][Full Text] [Related]
12. Child Neurology: Ethylmalonic encephalopathy.
Govindaraj P; Parayil Sankaran B; Nagappa M; Arvinda HR; Deepha S; Jessiena Ponmalar JN; Sinha S; Gayathri N; Taly AB
Neurology; 2020 Mar; 94(12):e1336-e1339. PubMed ID: 32111695
[No Abstract] [Full Text] [Related]
13. Successful treatment of a patient with ethylmalonic encephalopathy by intravenous N-acetylcysteine.
Kılıç M; Dedeoğlu Ö; Göçmen R; Kesici S; Yüksel D
Metab Brain Dis; 2017 Apr; 32(2):293-296. PubMed ID: 27830356
[TBL] [Abstract][Full Text] [Related]
14. Improved clinical outcome following liver transplant in patients with ethylmalonic encephalopathy.
Tam A; AlDhaheri NS; Mysore K; Tessier ME; Goss J; Fernandez LA; D'Alessandro AM; Schwoerer JS; Rice GM; Elsea SH; Scaglia F
Am J Med Genet A; 2019 Jun; 179(6):1015-1019. PubMed ID: 30864297
[TBL] [Abstract][Full Text] [Related]
15. Morphologic evidence of diffuse vascular damage in human and in the experimental model of ethylmalonic encephalopathy.
Giordano C; Viscomi C; Orlandi M; Papoff P; Spalice A; Burlina A; Di Meo I; Tiranti V; Leuzzi V; d'Amati G; Zeviani M
J Inherit Metab Dis; 2012 May; 35(3):451-8. PubMed ID: 22020834
[TBL] [Abstract][Full Text] [Related]
16. Severe early onset ethylmalonic encephalopathy with West syndrome.
Papetti L; Garone G; Schettini L; Giordano C; Nicita F; Papoff P; Zeviani M; Leuzzi V; Spalice A
Metab Brain Dis; 2015 Dec; 30(6):1537-45. PubMed ID: 26194623
[TBL] [Abstract][Full Text] [Related]
17. Imaging features of acquired pediatric metabolic and toxic white matter disorders.
Filatov A; Milla S; Shekdar K; Hygino da Cruz C; Fatterpekar GM
Top Magn Reson Imaging; 2011 Oct; 22(5):239-50. PubMed ID: 24562093
[TBL] [Abstract][Full Text] [Related]
18. Ethylmalonic encephalopathy: application of improved biochemical and molecular diagnostic approaches.
Drousiotou A; DiMeo I; Mineri R; Georgiou T; Stylianidou G; Tiranti V
Clin Genet; 2011 Apr; 79(4):385-90. PubMed ID: 20528888
[TBL] [Abstract][Full Text] [Related]
19. Multiple sources of metabolic disturbance in ETHE1-related ethylmalonic encephalopathy.
Barth M; Ottolenghi C; Hubert L; Chrétien D; Serre V; Gobin S; Romano S; Vassault A; Sefiani A; Ricquier D; Boddaert N; Brivet M; de Keyzer Y; Munnich A; Duran M; Rabier D; Valayannopoulos V; de Lonlay P
J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S443-53. PubMed ID: 20978941
[TBL] [Abstract][Full Text] [Related]
20. Genotypic Spectrum and Natural History of Cavitating Leukoencephalopathies in Childhood.
Zhang J; Liu M; Zhang Z; Zhou L; Kong W; Jiang Y; Wang J; Xiao J; Wu Y
Pediatr Neurol; 2019 May; 94():38-47. PubMed ID: 30770271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
